These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 30063126)
1. Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation. Dong H; Wang W; Mo S; Liu Q; Chen X; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J; Hu J J Cell Mol Med; 2018 Oct; 22(10):4935-4947. PubMed ID: 30063126 [TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG14 promotes hepatocellular carcinoma progression via H3K27 acetylation activated PABPC1 by PTEN signaling. Zhang H; Xu HB; Kurban E; Luo HW Cell Death Dis; 2020 Aug; 11(8):646. PubMed ID: 32811821 [TBL] [Abstract][Full Text] [Related]
3. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918 [TBL] [Abstract][Full Text] [Related]
4. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694 [TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer. Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837 [TBL] [Abstract][Full Text] [Related]
6. LncRNA PRBC induces autophagy to promote breast cancer progression through modulating PABPC1-mediated mRNA stabilization. Liang Y; Chen B; Xu F; Long L; Ye F; Wang Y; Luo D; Li Y; Zhao W; Wang L; Jin Y; Wang L; Kong X; Su P; Yang Q Oncogene; 2024 Mar; 43(14):1019-1032. PubMed ID: 38366145 [TBL] [Abstract][Full Text] [Related]
7. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer. Sun Z; Zhang C; Wang T; Shi P; Tian X; Guo Y J Cancer Res Ther; 2019; 15(4):933-940. PubMed ID: 31436255 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1. Zhu HY; Bai WD; Ye XM; Yang AG; Jia LT Biochem Biophys Res Commun; 2018 Feb; 496(4):1308-1313. PubMed ID: 29408336 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer. Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004 [TBL] [Abstract][Full Text] [Related]
10. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway. Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319 [TBL] [Abstract][Full Text] [Related]
11. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity. Zheng Z; Chen M; Xing P; Yan X; Xie B Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994 [TBL] [Abstract][Full Text] [Related]
12. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers. Baldassarre T; Truesdell P; Craig AW Breast Cancer Res; 2017 Oct; 19(1):110. PubMed ID: 28974266 [TBL] [Abstract][Full Text] [Related]
13. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis. Liu Z; Yan Y; Cao S; Chen Y J Cell Biochem; 2018 Aug; 119(8):6905-6913. PubMed ID: 29667771 [TBL] [Abstract][Full Text] [Related]
15. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer. Jiao P; Hou J; Yao M; Wu J; Ren G Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267 [TBL] [Abstract][Full Text] [Related]
16. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway. Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis. Dong H; Yang C; Chen X; Sun H; He X; Wang W Breast Cancer; 2023 Nov; 30(6):1028-1040. PubMed ID: 37653187 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA SNHG14 enhances migration and invasion of ovarian cancer by upregulating DGCR8. Zhao JL; Wang CL; Liu YL; Zhang GY Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10226-10233. PubMed ID: 31841176 [TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG14 accelerates breast cancer progression through sponging miR-543 and regulating KLF7 expression. Zhang D; Ding X; Peng M Arch Gynecol Obstet; 2022 Jun; 305(6):1507-1516. PubMed ID: 34783894 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG14 promotes osteosarcoma progression via miR-433-3p/FBXO22 axis. Hou XK; Mao JS Biochem Biophys Res Commun; 2020 Mar; 523(3):766-772. PubMed ID: 31948764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]